Evidence map›Paper›PMID 34925011›Full record

ArticleFrontiers in pharmacology2021

A Traditional Chinese Medicine Formula Danshen Baibixiao Ameliorates Imiquimod-Induced Psoriasis-Like Inflammation in Mice.

Xiaoqi Jin, Hongfeng Xu, Chuanqi Huang, Haoran Ma, Xin Xiong, Lu Cheng, Fuqian Wang, Yan Feng, Geng Zhang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Anti-psoriatic potential of nanocarrier formulated with Deverra tortuosa DC. and Deverra triradiata hochst aerial extracts: in vivo evaluation in mice.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2026
    Article
  3. A review of core immuno-inflammatory mechanisms and key regulatory targets in psoriasis.American journal of clinical and experimental immunology · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Gut microbiota and psoriasis: pathogenesis, targeted therapy, and future directions.Frontiers in cellular and infection microbiology · 2024
    Review
  11. Review
  12. Protective effects of extracts fromFrontiers in pharmacology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Xiaoqi JinSchool of Pharmacy, Hubei University of Chinese Medicine, Wuhan, China.
Hongfeng XuDepartment of Pharmacy, Wuhan Hospital of Traditional Chinese and Western Medicine, Wuhan, China.
Chuanqi HuangDepartment of Pharmacy, Wuhan Hospital of Traditional Chinese and Western Medicine, Wuhan, China.
Haoran MaDepartment of Pharmacy, Wuhan Hospital of Traditional Chinese and Western Medicine, Wuhan, China.
Xin XiongDepartment of Pharmacy, Wuhan Hospital of Traditional Chinese and Western Medicine, Wuhan, China.
Lu ChengDepartment of Pharmacy, Wuhan Hospital of Traditional Chinese and Western Medicine, Wuhan, China.
Fuqian WangDepartment of Pharmacy, Wuhan Hospital of Traditional Chinese and Western Medicine, Wuhan, China.
Yan FengDepartment of Pathology, Wuhan Hospital of Traditional Chinese and Western Medicine, Wuhan, China.
Geng ZhangSchool of Pharmacy, Hubei University of Chinese Medicine, Wuhan, China.
Wuhan No.1 Hospital · CNHubei University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

IL-23/TH-17 axisMAPKNF-κBSTAT3traditional Chinese medicine

Identifiers

PMID34925011
PMCPMC8678074
OpenAlexW4200492282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.